about
Warfarin interaction with Matricaria chamomillaElderly patients and inflammatory bowel diseaseApixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based reviewThe nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillationUtilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapyIn vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitorComparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarolHerb-drug interactions: review and assessment of report reliabilityThe effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteersVKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarkerMeasurement of warfarin in the oral fluid of patients undergoing anticoagulant oral therapyInfluence of sampling on the determination of warfarin and warfarin alcohols in oral fluidComparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort StudyAnticoagulation with warfarin in infants and children.Estimation of optimal dynamic anticoagulation regimes from observational data: a regret-based approach.Thyroid, hemostasis and thrombosis.Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition.Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting.Effects of neferine on the pharmacokinetics of amiodarone in rats.Use of oral anticoagulants in older patients.The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence.Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.Levofloxacin and warfarin interaction.Drug interaction presenting as acute abdomen.Fenofibrate potentiates warfarin effects.Study protocol: the DESPATCH study: delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcarePharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.Using highly variable warfarin dosing to identify patients at risk for adverse events.Azathioprine-induced warfarin resistance.Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality.Ximelagatran: the first oral direct thrombin inhibitor.Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database.Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin.Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations.Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes.Interaction of warfarin with drugs, natural substances, and foods.Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.
P2860
Q24542494-9CD26D1A-9835-42C9-905B-236079DF14E9Q26768270-5EB990AD-9E8B-4F08-B93A-B8E50F4691C6Q26783455-79107740-1D99-49FB-BEB0-724D4A00574FQ28194361-B00B74A5-7D95-4514-9C80-37C5F3C67490Q28199840-2DD7F386-73CB-4AF3-9AD1-BE0538938555Q28238054-ABC3616F-9B98-4F3C-A052-C1159BF6F70DQ28288315-031AB7CD-46F2-4ACA-BFBB-C6A3F3AB4F0CQ28365912-B19E7D98-F93B-469F-9AC6-10AFFC62D91FQ28367502-DBF27E95-9E72-4779-AF70-D8354F502F7AQ28476502-DF27499E-7969-4136-A260-C2EDB5D55D40Q28478229-0C06BD93-C66E-4B8D-A097-1E3DD599EFCDQ28542544-B81D97CA-D96E-47D9-939C-284B8D0E85CDQ28552407-B4465E6B-3C91-485E-85A1-98EB4B272CA1Q30469622-7D3D13B8-C2B9-4458-9BDD-E266A4A096AEQ31061368-0A5A88F7-4F39-42B7-92E9-0A4EB79C5D21Q33365293-9B0D7FD3-0944-4E88-B0FD-3D8FE4FC7F0FQ33497257-1A80FDC2-25F2-4B39-9A9A-59683F219539Q33680181-CB92D2CB-3F2B-4ED8-9D3E-D4EFA8D44C80Q33950584-BD05BB9D-588D-4D87-956E-B0B57A295602Q34000901-86598B44-75A4-48A4-BDB4-16FDF4338C58Q34042836-B5B8B961-3F5D-4850-BE81-5B6596C6F77AQ34122540-6E0A288E-C9C6-420A-83D4-541DA946D477Q34283903-12916320-978B-4AED-91DB-A979F98433BFQ34723631-AD3B61E7-71BF-45EE-AE34-E5AF8114E67FQ34874328-5E7F653D-29C7-4227-9A80-8E8620558264Q34962730-30BA6C08-131D-4949-8702-97D4C88B749FQ35054251-74565986-0F3D-4BC6-B0BB-D3DE8D8AABE1Q35063716-D9EE2E32-DC42-456B-85C6-CEA733385C9AQ35204081-2DC844C9-14FF-448E-947A-7EFBA82043EBQ35415257-733D0065-6EE4-4ADE-A329-498B913BE866Q35633727-D08F2EAF-BA35-445F-B4C1-68ECD5FFBDECQ35698491-5FBFAB9B-365B-45F3-8CD2-05E06DD9A574Q35753482-759A9CEF-D132-4D56-9C0B-8CE8173EAA2CQ35754760-4FA5D24A-244F-4957-8DAA-9714FA0C8AFCQ35777336-970BB00F-D54E-405C-A0FE-1EBADE4B851EQ35803836-A24850CD-BAA9-4489-93CF-A7E256D09463Q35843864-58946D9C-4805-43BB-9ED6-E629E7CFD82CQ35873687-7237681C-C0D7-4343-9570-44C1CBF57154Q36007599-1937EE86-664B-4A62-BB1F-EF0464E512FCQ36054968-D4345650-C97D-4573-9772-1A54F87275F5
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Interactions of warfarin with drugs and food.
@en
type
label
Interactions of warfarin with drugs and food.
@en
prefLabel
Interactions of warfarin with drugs and food.
@en
P2093
P1476
Interactions of warfarin with drugs and food.
@en
P2093
P304
P356
10.7326/0003-4819-121-9-199411010-00009
P407
P577
1994-11-01T00:00:00Z